ProKidney Corp.
Cash Flow

Last updated:

Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of ProKidney Corp. generated cash of -$90,069,000, which is less than the previous year. Cash used in financing activities reached the amount of -$9,551,000 last year. Net change in cash is therefore -$429,603,000.

Cash Flow

ProKidney Corp. (NASDAQ:PROK): Cash Flow
2019 -76.80K -2.96K 20K
2020 -25.18M -5.45M 19.98M
2021 -50.29M -5.19M 71.47M
2022 -77.08M -1.73M 548.52M
2023 -90.06M -329.98M -9.55M

PROK Cash Flow Statement (2019 – 2023)

2023 2022 2021 2020 2019
Cash at beginning of period
490.25M20.55M4.57M15.22M0
Operating activities
Net income
-135.44M-148.13M-55.14M-26.74M-79.61K
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
3.85M3.03M1.98M964K867
Stock-based compensation expense
30.84M74.46K699K730K498
Deferred income tax benefit 30.84M74.46K699K730K498
Changes in operating assets and liabilities:
Accounts receivable, net
00000
Inventories
00000
Accounts payable
11.63M494K5K683K0
Cash generated by operating activities
-90.06M-77.08M-50.29M-25.18M-76.80K
Investing activities
Purchases Of Investments
-471.60M0000
Investments In Property Plant And Equipment
-34.19M-1.84M-5.19M-5.45M-1.30K
Acquisitions Net
0108K1K0-1.66K
Cash generated by investing activities
-329.98M-1.73M-5.19M-5.45M-2.96K
Financing activities
Common Stock Issued
06.05M71.5M00
Payments for dividends
00000
Repurchases of common stock
-9.49M0000
Repayments of term debt
-52K-32K-30K-11K0
Cash used in financing activities
-9.55M548.52M71.47M19.98M20K
Net Change In Cash
-429.60M469.69M15.98M-10.64M15.22K
Cash at end of period
60.64M490.25M20.55M4.57M15.22K
Data sourceData sourceData source